Eledon Pharmaceuticals Stock Revenue
| ELDN Stock | USD 2.39 0.02 0.84% |
Eledon Pharmaceuticals fundamentals help investors to digest information that contributes to Eledon Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Eledon Stock. The fundamental analysis module provides a way to measure Eledon Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Eledon Pharmaceuticals stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 120 K | 0.0 |
Eledon | Revenue |
Eledon Pharmaceuticals Company Revenue Analysis
Eledon Pharmaceuticals' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Eledon
Projected quarterly revenue analysis of Eledon Pharmaceuticals provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Eledon Pharmaceuticals match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Eledon Pharmaceuticals' stock price.
Eledon Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Eledon Pharmaceuticals is extremely important. It helps to project a fair market value of Eledon Stock properly, considering its historical fundamentals such as Revenue. Since Eledon Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Eledon Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Eledon Pharmaceuticals' interrelated accounts and indicators.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Eledon Pharmaceuticals reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Eledon Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Eledon Pharmaceuticals' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Eledon Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eledon Pharmaceuticals by comparing valuation metrics of similar companies.Eledon Pharmaceuticals is currently under evaluation in revenue category among related companies.
Eledon Pharmaceuticals Institutional Holders
Institutional Holdings refers to the ownership stake in Eledon Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Eledon Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Eledon Pharmaceuticals' value.| Shares | Northern Trust Corp | 2023-12-31 | 39.9 K | Blackrock Inc | 2023-12-31 | 28.3 K | Millennium Management Llc | 2023-12-31 | 22.9 K | Mercer Global Advisors Inc. | 2023-12-31 | 16.7 K | Charles Schwab Investment Management Inc | 2023-12-31 | 15 K | Pathstone Holdings Llc | 2023-12-31 | 13 K | Pathstone Family Office, Llc | 2023-09-30 | 13 K | Two Sigma Securities, Llc | 2023-12-31 | 11.8 K | Rmb Capital Management, Llc | 2023-09-30 | 10 K | Bvf Inc | 2023-09-30 | 4.3 M | Armistice Capital, Llc | 2023-12-31 | 2.2 M |
Eledon Fundamentals
| Return On Equity | -0.48 | ||||
| Return On Asset | -0.3 | ||||
| Current Valuation | 8.09 M | ||||
| Shares Outstanding | 24.81 M | ||||
| Shares Owned By Insiders | 5.42 % | ||||
| Shares Owned By Institutions | 38.75 % | ||||
| Number Of Shares Shorted | 31.13 K | ||||
| Price To Book | 0.50 X | ||||
| EBITDA | (42.63 M) | ||||
| Net Income | (40.33 M) | ||||
| Cash And Equivalents | 70.46 M | ||||
| Cash Per Share | 5.12 X | ||||
| Total Debt | 383 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 22.22 X | ||||
| Book Value Per Share | 3.44 X | ||||
| Cash Flow From Operations | (39.53 M) | ||||
| Short Ratio | 0.25 X | ||||
| Earnings Per Share | (1.64) X | ||||
| Price To Earnings To Growth | 0.01 X | ||||
| Target Price | 15.6 | ||||
| Number Of Employees | 20 | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 58.81 M | ||||
| Total Asset | 125.89 M | ||||
| Retained Earnings | (243.19 M) | ||||
| Working Capital | 52.23 M | ||||
| Net Asset | 125.89 M |
About Eledon Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eledon Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eledon Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eledon Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Eledon Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Eledon Pharmaceuticals' short interest history, or implied volatility extrapolated from Eledon Pharmaceuticals options trading.
Pair Trading with Eledon Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eledon Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Eledon Stock
| 0.49 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.45 | EVOK | Evoke Pharma | PairCorr |
| 0.42 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Eledon Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eledon Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eledon Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eledon Pharmaceuticals to buy it.
The correlation of Eledon Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eledon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eledon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eledon Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Eledon Pharmaceuticals Piotroski F Score and Eledon Pharmaceuticals Altman Z Score analysis. To learn how to invest in Eledon Stock, please use our How to Invest in Eledon Pharmaceuticals guide.Note that the Eledon Pharmaceuticals information on this page should be used as a complementary analysis to other Eledon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Eledon Stock analysis
When running Eledon Pharmaceuticals' price analysis, check to measure Eledon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eledon Pharmaceuticals is operating at the current time. Most of Eledon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eledon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eledon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eledon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Eledon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eledon Pharmaceuticals. If investors know Eledon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eledon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Return On Assets (0.30) | Return On Equity (0.48) |
The market value of Eledon Pharmaceuticals is measured differently than its book value, which is the value of Eledon that is recorded on the company's balance sheet. Investors also form their own opinion of Eledon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eledon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eledon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eledon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eledon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eledon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eledon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.